-
Recognizing that patients and consumers are the key players in healthcare, all employees are recommended to spend 1% of their working hours with patients
-
We strive to improve access to medicines through the development and provision of innovative medicines.
-
February 25, 2020
-
February 21, 2020
-
January 30, 2020
EISAI TO SUPPORT COUNTER MEASURES FOR CHINA’S NOVEL CORONAVIRUS-ASSOCIATED PNEUMONIA SPREAD IN CHINA
-
January 29, 2020
-
January 23, 2020
-
February 3, 2020
-
January 31, 2020
IR “Third Quarter Financial Report for the Fiscal Year Ending March 31, 2020”
-
December 11, 2019
-
November 27, 2019
-
February 14, 2020
EISAI TO VOLUNTARILY WITHDRAW ANTIOBESITY AGENT BELVIQ® / BELVIQ XR® IN THE U.S.
-
October 18, 2019
EISAI JOINS WORLD ECONOMIC FORUM AS STRATEGIC PARTNER ASSOCIATE
-
July 8, 2019
-
July 4, 2019
-
December 6, 2018
EISAI JOINS WORLD ECONOMIC FORUM CENTRE FOR THE FOURTH INDUSTRIAL REVOLUTION JAPAN
Eisai's hhc Philosophy
Sustainability
28 countries 1.97 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of January 2020)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
